Kromerizska Nemocnice A S

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Bladder cancer2 trials
• Heart failure1 trial
• Stroke1 trial

Phase

• Phase 33 trials

Status

• Recruiting2 trials
• Completed1 trial

Lead sponsor

• Ferring Pharmaceuticals2 trials
• Bayer1 trial

Running trials

• Recruiting

  Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

  NCT06510374· Phase 3· Ferring Pharmaceuticals· Source

• Recruiting

  A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

  NCT06545955· Phase 3· Ferring Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bladder cancer2 recruiting

Closed trials

• Completed

  Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%

  NCT04435626· Phase 3· Bayer· Source